Mabion SA Sustainability Reports
Mabion S.A. is a biotechnology company focused on the development and production of biopharmaceuticals, particularly biosimilars for the treatment of cancer and autoimmune diseases.
Sector: Health Care
Country: Poland
Exchange: Warsaw Stock Exchange
ISIN: PLMBION00016
12 reports from 2016 to 2025
Company Profile
Mabion SA
Mabion S.A. is a biotechnology company focused on the development and production of biopharmaceuticals, particularly biosimilars for the treatment of cancer and autoimmune diseases.
Reports